Sosei Heptares bags another big partnership, this time with Takeda
gastrointestinal, GPCR, Heptares, partnering, Sosei, Takeda
0 Comment
Heptares
Sosei see Teva pipeline cull as an opportunity
CGRP, Heptares, migraine, Sosei, Teva
0 Comment
Troubled generics giant Teva is continuing the heavy pruning of its business and has cut a novel migraine drug from its pipeline.
MSD attracts top British scientist to head up UK discovery centre
Heptares, Merck & Co, MSD, MSD UK Discovery Research Centre
0 Comment
Dr Fiona Marshall joins MSD from Sosei from Heptares, the UK biotech company she co-founded more than a decade ago, and which was acquired by Sosei in 2015.
AZ pays Heptares $10m as cancer trial begins
AstraZeneca, Bristol-Myers Squibb, cancer, Heptares, immuno-oncology
0 Comment
Phase 1 study of immuno-oncology drug candidate begins.